BioCardia, Inc.: Form 10-Q for the period ended Jun 30, 2013
Filed with the SEC on Jul 26, 2013 and accepted by EDGAR at Jul 26, 2013, 10:31 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2013-06-30. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Cost of revenue | 3 months2013-04-01 to 2013-06-30 | $0 | us-gaap:CostOfRevenue |
| Cost of revenue | 6 months2013-01-01 to 2013-06-30 | $0 | us-gaap:CostOfRevenue |
| Gross profit | 3 months2013-04-01 to 2013-06-30 | $69.0k | us-gaap:GrossProfit |
| Gross profit | 6 months2013-01-01 to 2013-06-30 | $107.0k | us-gaap:GrossProfit |
| Operating income | 3 months2013-04-01 to 2013-06-30 | $6.0k | us-gaap:OperatingIncomeLoss |
| Operating income | 6 months2013-01-01 to 2013-06-30 | −$20.0k | us-gaap:OperatingIncomeLoss |
| Income tax | 3 months2013-04-01 to 2013-06-30 | $0 | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 6 months2013-01-01 to 2013-06-30 | $0 | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2013-04-01 to 2013-06-30 | $9.0k | us-gaap:NetIncomeLoss |
| Net income | 6 months2013-01-01 to 2013-06-30 | −$16.0k | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2013-04-01 to 2013-06-30 | $0.00 | us-gaap:EarningsPerShareBasicAndDiluted |
| Diluted EPS | 6 months2013-01-01 to 2013-06-30 | $0.00 | us-gaap:EarningsPerShareBasicAndDiluted |
| Diluted shares (weighted) | 3 months2013-04-01 to 2013-06-30 | 230,293,141 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 6 months2013-01-01 to 2013-06-30 | 230,293,141 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 6 months2013-01-01 to 2013-06-30 | $1.0k | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Cash and equivalents | At period end2013-06-30 | $13.3m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Total assets | At period end2013-06-30 | $13.3m | us-gaap:Assets |
| Total liabilities | At period end2013-06-30 | $3.0k | us-gaap:Liabilities |
| Shareholders' equity | At period end2013-06-30 | $13.3m | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001136261-13-000323. Last ingested by Listed: Nov 13, 2026, 15:46 ET. Listed shows no prices and gives no investment advice.